Tumor Ablation Market Report by Technology (Radiofrequency (RF) Ablation, Microwave Ablation, Cryoablation, and Others), Mode of Treatment (Percutaneous Ablation, Laparoscopic Ablation, Surgical Ablation), Mode of Application (Liver Cancer, Lung Cancer, Kidney Cancer, Bone Metastasis, and Others), End-User (Hospitals, Cancer Specialty Clinics, and Others), and Region 2024-2032
The global tumor ablation market size reached US$ 1,200 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 3,100 Million by 2032, exhibiting a growth rate (CAGR) of 10.8% during 2024-2032. The increasing incidence of cancer cases across the globe, continual advancements in medical technology, and growing awareness about minimally invasive cancer treatments among the masses represent some of the factors that are propelling the market.
Tumor ablation is a medical procedure that involves the removal or destruction of abnormal tissue, particularly cancerous tumors, without the need for surgical excision. Employing various techniques such as radiofrequency, laser, microwave, or cryoablation, this minimally invasive approach targets cancerous cells and eradicates them with precision. The process is characterized by its ability to minimize damage to surrounding healthy tissues, thereby reducing recovery time and improving the patient's quality of life. These treatments are typically guided by imaging technologies such as ultrasound, CT scans, or MRI, which provide real-time data for higher accuracy.
The global market for tumor ablation is primarily driven by the increasing incidence of cancer cases across the globe. In line with this, continual advancements in medical technology are providing an impetus to the market. Moreover, the growing awareness about minimally invasive cancer treatments among the masses is acting as a significant growth-inducing factor for the market. In addition to this, the aging population, which is more susceptible to cancer, is resulting in higher investment in tumor ablation therapies. Besides this, healthcare systems' focus on reducing surgical complications is creating lucrative opportunities in the market. Also, the emergence of precision medicine is positively impacting the market. The market is further propelled by increased healthcare expenditure, particularly in developed countries. Some of the other factors contributing to the market include the rise of medical tourism, greater accessibility to advanced healthcare facilities, and extensive research and development (R&D) activities.
Tumor Ablation Market Trends/Drivers:
Rise in the patient-centric approaches
The modern healthcare landscape is increasingly focusing on personalized care, with treatments being tailored to meet the unique needs and circumstances of each patient. This shift towards patient-centricity has been a game-changer for the tumor ablation market. By designing therapies that consider various patient factors such as age, medical history, and genetic predispositions, healthcare providers are creating highly targeted and effective treatment plans. This personalized approach is particularly important for cancer patients, who often have unique therapeutic responses due to the heterogeneous nature of tumors. By leveraging data analytics, genomics, and personalized medical histories, healthcare providers are better equipped to select the most appropriate tumor ablation therapy for individual patients. This higher degree of personalization not only improves the efficacy of treatments but also increases patient satisfaction and trust, which in turn encourages more people to opt for tumor ablation therapies.
Increasing integration of digital technologies
The integration of digital technologies such as artificial intelligence (AI), machine learning, and big data analytics into healthcare systems is a driving force behind the expansion of the market. These technologies enable healthcare providers to make more informed decisions based on comprehensive data analysis, including patient histories, real-time monitoring, and predictive modeling. These digital advancements are not just limited to patient diagnosis and treatment plans. They also extend to the operational aspects of healthcare systems, streamlining the administration, reducing overhead costs, and improving the efficiency of delivering care. Digital technologies facilitate the real-time sharing of information across different departments or even different healthcare facilities, making it easier to coordinate patient care and adapt treatments as required. This enhanced operational efficiency not only improves patient outcomes but also makes the adoption of tumor ablation therapies more financially viable for healthcare systems.
Rising partnerships and acquisitions amongst key players
The influx of investment from both public and private sectors plays a critical role in shaping the market. Government grants, subsidies, and public funding serve as foundational support for research and development in the healthcare sector. These funds enable medical researchers to explore innovative techniques and technologies in tumor ablation without the immediate pressure of market viability. On the other side, private investment, often in the form of venture capital, accelerates the commercialization process of these new technologies. The alignment of public and private financial interests can often yield breakthrough innovations, as it brings together academic rigor and market-oriented approaches. For instance, public funding can support the early-stage research needed to develop a novel tumor ablation technique, while private investment can facilitate the clinical trials and marketing required to bring it to market. This dual investment stream not only accelerates the pace of innovation but also creates a more robust and dynamic market landscape, fostering competitiveness and, consequently, driving market growth.
Tumor Ablation Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global tumor ablation market report, along with forecasts at the global and regional levels for 2024-2032. Our report has categorized the market based on technology, mode of treatment, mode of application and end-user.
Breakup by Technology:
Radiofrequency (RF) Ablation
Microwave Ablation
Cryoablation
Others
Radiofrequency (RF) ablation represents the largest market segment
The report has provided a detailed breakup and analysis of the market based on the technology. This includes radiofrequency (RF) ablation, microwave ablation, cryoablation and others. According to the report, radiofrequency (RF) ablation represented the largest segment.
The radiofrequency (RF) ablation segment is primarily driven by its high efficacy rates, shorter procedure times, and minimally invasive nature. Technological advancements have made RF ablation more precise and safe, attracting physicians and patients alike. Moreover, the cost-effectiveness compared to traditional surgical methods has further boosted its adoption. Reimbursement policies have also been favorable, encouraging the use of RF ablation for tumor treatments. Overall, these factors contribute to its major share in the global tumor ablation market.
On the other hand, microwave, cryoablation, and other methods are becoming increasingly popular due to advancements in technology. They offer alternatives to RF ablation but tend to be more expensive and less covered by insurance. Their adoption is also limited by the need for specialized training for healthcare providers. Despite these challenges, they hold a minor but growing segment in the market.
Breakup by Mode of Treatment:
Percutaneous Ablation
Laparoscopic Ablation
Surgical Ablation
Surgical ablation accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the mode of treatment. This includes percutaneous ablation, laparoscopic ablation, and surgical ablation. According to the report, surgical ablation represented the largest segment.
Surgical ablation remains a conventional and highly effective approach for treating various types of tumors. It is often recommended for cases where the tumor is large or not amenable to minimally invasive techniques. Given the invasive nature, surgical ablation usually necessitates longer hospital stays and recovery periods, which can be a downside. However, its proven efficacy and completeness in tumor removal secure its significant role in the global market.
On the other hand, percutaneous and laparoscopic methods are minimally invasive and preferred for small to medium-sized tumors. These techniques are cost-effective but require specialized equipment and training. Their minor market share is partly due to limitations in treating complex or larger tumors. Nonetheless, they remain valuable options in the broader scope of ablation methods.
Breakup by Mode of Application:
Liver Cancer
Lung Cancer
Kidney Cancer
Bone Metastasis
Others
Liver cancer represents the largest market segment
The report has provided a detailed breakup and analysis of the market based on the mode of application. This includes liver cancer, lung cancer, kidney cancer, bone metastasis and others. According to the report, liver cancer represented the largest segment.
Liver cancer dominates the global tumor ablation market, largely due to the high incidence and mortality rates associated with this disease. The ablation techniques offer a viable treatment option for early-stage liver cancer, where surgical removal may not be feasible. As liver cancer is often diagnosed at an advanced stage, ablation techniques are viewed as essential palliative treatments. High adoption rates and the emphasis on research for liver cancer ablation contribute to its significant market share.
On the other hand, the other segments including lung, kidney, and bone metastasis are gradually gaining traction due to technological improvements. These cancers are typically treated with other therapies, but ablation is becoming a more common secondary or complementary option. Limitations in insurance coverage and less substantial clinical evidence compared to major segments hold back their market share.
Breakup by End-User:
Hospitals
Cancer Specialty Clinics
Others
Hospitals accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the end-user. This includes hospitals, cancer specialty clinics and others. According to the report, hospitals represented the largest segment.
Hospitals constitute a significant share of the market due to their comprehensive healthcare services and accessibility to a wide patient demographic. They have the financial capability to invest in advanced ablation technologies, and their multidisciplinary teams can offer a variety of treatment options. With the increasing incidence of cancer, hospitals continue to adopt tumor ablation techniques, solidifying their role in the global market.
On the other hand, specialized cancer clinics focus exclusively on cancer treatment, making them ideal centers for advanced ablation therapies. These clinics often have cutting-edge technologies and highly skilled specialists, which makes them attractive for patients seeking specialized care. However, these centers may not be as widespread as hospitals, limiting their accessibility. Their specific focus and expertise, though, contribute to an increasing share in the global market.
Breakup by Region:
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
North America exhibits a clear dominance, accounting for the largest tumor ablation market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America; Europe; Asia Pacific; the Middle East and Africa; and Latin America. According to the report, North America accounted for the largest market share.
North America holds a dominant position in the global market, driven by a number of factors including high healthcare expenditure, advanced medical technologies, and a robust healthcare infrastructure. The region also benefits from favorable reimbursement policies, which make various ablation treatments more accessible to patients. Furthermore, the prevalence of cancer is relatively high in North America, leading to greater demand for effective treatment methods such as tumor ablation.
Research and development (R&D) activities in the region are vigorous, further propelling the adoption of new and improved ablation techniques. Pharmaceutical and medical device companies in North America also contribute to market growth by investing in research, thereby enhancing the technology and its applications. The presence of key market players headquartered in the region adds to the competitive advantage. Educational campaigns and patient awareness programs are also more prevalent here, aiding in early diagnosis and treatment.
Competitive Landscape:
Leaders in the global tumor ablation market are dedicating resources to clinical trials and research to improve the efficacy and safety of their solutions. They are also focusing on developing minimally invasive techniques to cater to patient comfort and faster recovery. Telehealth integrations are in progress to facilitate remote consultations, thereby increasing the adoption rate of their products. Regulatory approvals are a key focus, and as such, these entities are navigating complex compliance landscapes both domestically and internationally. To maintain a competitive edge, alliances with healthcare providers and medical institutions, and implementation of robust after-sales support and training programs are being formed. Furthermore, educational programs for healthcare professionals are being launched to foster proper utilization of the technology.
The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
Medtronic Public Limited Company
AngioDynamics Inc.
HealthTronics Inc.
NeuWave Medical, Inc.
INTIO Inc.
Galil Medical Ltd
Boston Scientific Corporation
SonaCare Medical LLC
EDAP TMS S.A.
Erbe Elektromedizin GmbH
IceCure Medical Ltd
MISONIX Inc.
Endocare Inc.
CooperSurgical Inc.
B V M Meditech Pvt
Recent Developments:
In August 2023, Medtronic Public Limited Company received CE (Conformitй Europйenne) Mark approval for its Inceptiv closed-loop rechargeable spinal cord stimulator (SCS). It is the first Medtronic SCS device to offer a closed-loop feature that senses each person's unique biological signals and adjusts stimulation moment to moment, as needed, to keep therapy in harmony with the motions of daily life.
In March 2023, AngioDynamics announced several new partnerships with AddLife in the UK, Ireland & Nordics markets. The new distribution arrangements will see Healthcare 21, part of the AddLife Group, distribute AngioDynamics’ oncology and surgical product portfolio in the UK and Ireland, and Mediplast in the Nordics.
In August 2023, Boston Scientific Corporation (NYSE: BSX) today announced positive 12-month results from the pivotal ADVENT clinical trial of the FARAPULSE Pulsed Field Ablation (PFA) System, a nonthermal treatment in which electric fields selectively ablate heart tissue in patients with atrial fibrillation (AF). The study is the first randomized clinical trial to directly compare the efficacy and safety of the FARAPULSE PFA System against standard-of-care ablation – either radiofrequency or cryoablation – for the treatment of patients with paroxysmal, or intermittent, AF.
Key Questions Answered in This Report
1. What was the size of the global tumor ablation market in 2023?
2. What is the expected growth rate of the global tumor ablation market during 2024-2032?
3. What has been the impact of COVID-19 on the global tumor ablation market?
4. What are the key factors driving the global tumor ablation market?
5. What is the breakup of the global tumor ablation market based on the technology?
6. What is the breakup of the global tumor ablation market based on the mode of treatment?
7. What is the breakup of the global tumor ablation market based on mode of application?
8. What is the breakup of the global tumor ablation market based on the end-user?
9. What are the key regions in the global tumor ablation market?
10. Who are the key players/companies in the global tumor ablation market?
Tumor ablation is a medical procedure that involves the removal or destruction of abnormal tissue, particularly cancerous tumors, without the need for surgical excision. Employing various techniques such as radiofrequency, laser, microwave, or cryoablation, this minimally invasive approach targets cancerous cells and eradicates them with precision. The process is characterized by its ability to minimize damage to surrounding healthy tissues, thereby reducing recovery time and improving the patient's quality of life. These treatments are typically guided by imaging technologies such as ultrasound, CT scans, or MRI, which provide real-time data for higher accuracy.
The global market for tumor ablation is primarily driven by the increasing incidence of cancer cases across the globe. In line with this, continual advancements in medical technology are providing an impetus to the market. Moreover, the growing awareness about minimally invasive cancer treatments among the masses is acting as a significant growth-inducing factor for the market. In addition to this, the aging population, which is more susceptible to cancer, is resulting in higher investment in tumor ablation therapies. Besides this, healthcare systems' focus on reducing surgical complications is creating lucrative opportunities in the market. Also, the emergence of precision medicine is positively impacting the market. The market is further propelled by increased healthcare expenditure, particularly in developed countries. Some of the other factors contributing to the market include the rise of medical tourism, greater accessibility to advanced healthcare facilities, and extensive research and development (R&D) activities.
Tumor Ablation Market Trends/Drivers:
Rise in the patient-centric approaches
The modern healthcare landscape is increasingly focusing on personalized care, with treatments being tailored to meet the unique needs and circumstances of each patient. This shift towards patient-centricity has been a game-changer for the tumor ablation market. By designing therapies that consider various patient factors such as age, medical history, and genetic predispositions, healthcare providers are creating highly targeted and effective treatment plans. This personalized approach is particularly important for cancer patients, who often have unique therapeutic responses due to the heterogeneous nature of tumors. By leveraging data analytics, genomics, and personalized medical histories, healthcare providers are better equipped to select the most appropriate tumor ablation therapy for individual patients. This higher degree of personalization not only improves the efficacy of treatments but also increases patient satisfaction and trust, which in turn encourages more people to opt for tumor ablation therapies.
Increasing integration of digital technologies
The integration of digital technologies such as artificial intelligence (AI), machine learning, and big data analytics into healthcare systems is a driving force behind the expansion of the market. These technologies enable healthcare providers to make more informed decisions based on comprehensive data analysis, including patient histories, real-time monitoring, and predictive modeling. These digital advancements are not just limited to patient diagnosis and treatment plans. They also extend to the operational aspects of healthcare systems, streamlining the administration, reducing overhead costs, and improving the efficiency of delivering care. Digital technologies facilitate the real-time sharing of information across different departments or even different healthcare facilities, making it easier to coordinate patient care and adapt treatments as required. This enhanced operational efficiency not only improves patient outcomes but also makes the adoption of tumor ablation therapies more financially viable for healthcare systems.
Rising partnerships and acquisitions amongst key players
The influx of investment from both public and private sectors plays a critical role in shaping the market. Government grants, subsidies, and public funding serve as foundational support for research and development in the healthcare sector. These funds enable medical researchers to explore innovative techniques and technologies in tumor ablation without the immediate pressure of market viability. On the other side, private investment, often in the form of venture capital, accelerates the commercialization process of these new technologies. The alignment of public and private financial interests can often yield breakthrough innovations, as it brings together academic rigor and market-oriented approaches. For instance, public funding can support the early-stage research needed to develop a novel tumor ablation technique, while private investment can facilitate the clinical trials and marketing required to bring it to market. This dual investment stream not only accelerates the pace of innovation but also creates a more robust and dynamic market landscape, fostering competitiveness and, consequently, driving market growth.
Tumor Ablation Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global tumor ablation market report, along with forecasts at the global and regional levels for 2024-2032. Our report has categorized the market based on technology, mode of treatment, mode of application and end-user.
Breakup by Technology:
Radiofrequency (RF) Ablation
Microwave Ablation
Cryoablation
Others
Radiofrequency (RF) ablation represents the largest market segment
The report has provided a detailed breakup and analysis of the market based on the technology. This includes radiofrequency (RF) ablation, microwave ablation, cryoablation and others. According to the report, radiofrequency (RF) ablation represented the largest segment.
The radiofrequency (RF) ablation segment is primarily driven by its high efficacy rates, shorter procedure times, and minimally invasive nature. Technological advancements have made RF ablation more precise and safe, attracting physicians and patients alike. Moreover, the cost-effectiveness compared to traditional surgical methods has further boosted its adoption. Reimbursement policies have also been favorable, encouraging the use of RF ablation for tumor treatments. Overall, these factors contribute to its major share in the global tumor ablation market.
On the other hand, microwave, cryoablation, and other methods are becoming increasingly popular due to advancements in technology. They offer alternatives to RF ablation but tend to be more expensive and less covered by insurance. Their adoption is also limited by the need for specialized training for healthcare providers. Despite these challenges, they hold a minor but growing segment in the market.
Breakup by Mode of Treatment:
Percutaneous Ablation
Laparoscopic Ablation
Surgical Ablation
Surgical ablation accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the mode of treatment. This includes percutaneous ablation, laparoscopic ablation, and surgical ablation. According to the report, surgical ablation represented the largest segment.
Surgical ablation remains a conventional and highly effective approach for treating various types of tumors. It is often recommended for cases where the tumor is large or not amenable to minimally invasive techniques. Given the invasive nature, surgical ablation usually necessitates longer hospital stays and recovery periods, which can be a downside. However, its proven efficacy and completeness in tumor removal secure its significant role in the global market.
On the other hand, percutaneous and laparoscopic methods are minimally invasive and preferred for small to medium-sized tumors. These techniques are cost-effective but require specialized equipment and training. Their minor market share is partly due to limitations in treating complex or larger tumors. Nonetheless, they remain valuable options in the broader scope of ablation methods.
Breakup by Mode of Application:
Liver Cancer
Lung Cancer
Kidney Cancer
Bone Metastasis
Others
Liver cancer represents the largest market segment
The report has provided a detailed breakup and analysis of the market based on the mode of application. This includes liver cancer, lung cancer, kidney cancer, bone metastasis and others. According to the report, liver cancer represented the largest segment.
Liver cancer dominates the global tumor ablation market, largely due to the high incidence and mortality rates associated with this disease. The ablation techniques offer a viable treatment option for early-stage liver cancer, where surgical removal may not be feasible. As liver cancer is often diagnosed at an advanced stage, ablation techniques are viewed as essential palliative treatments. High adoption rates and the emphasis on research for liver cancer ablation contribute to its significant market share.
On the other hand, the other segments including lung, kidney, and bone metastasis are gradually gaining traction due to technological improvements. These cancers are typically treated with other therapies, but ablation is becoming a more common secondary or complementary option. Limitations in insurance coverage and less substantial clinical evidence compared to major segments hold back their market share.
Breakup by End-User:
Hospitals
Cancer Specialty Clinics
Others
Hospitals accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the end-user. This includes hospitals, cancer specialty clinics and others. According to the report, hospitals represented the largest segment.
Hospitals constitute a significant share of the market due to their comprehensive healthcare services and accessibility to a wide patient demographic. They have the financial capability to invest in advanced ablation technologies, and their multidisciplinary teams can offer a variety of treatment options. With the increasing incidence of cancer, hospitals continue to adopt tumor ablation techniques, solidifying their role in the global market.
On the other hand, specialized cancer clinics focus exclusively on cancer treatment, making them ideal centers for advanced ablation therapies. These clinics often have cutting-edge technologies and highly skilled specialists, which makes them attractive for patients seeking specialized care. However, these centers may not be as widespread as hospitals, limiting their accessibility. Their specific focus and expertise, though, contribute to an increasing share in the global market.
Breakup by Region:
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
North America exhibits a clear dominance, accounting for the largest tumor ablation market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America; Europe; Asia Pacific; the Middle East and Africa; and Latin America. According to the report, North America accounted for the largest market share.
North America holds a dominant position in the global market, driven by a number of factors including high healthcare expenditure, advanced medical technologies, and a robust healthcare infrastructure. The region also benefits from favorable reimbursement policies, which make various ablation treatments more accessible to patients. Furthermore, the prevalence of cancer is relatively high in North America, leading to greater demand for effective treatment methods such as tumor ablation.
Research and development (R&D) activities in the region are vigorous, further propelling the adoption of new and improved ablation techniques. Pharmaceutical and medical device companies in North America also contribute to market growth by investing in research, thereby enhancing the technology and its applications. The presence of key market players headquartered in the region adds to the competitive advantage. Educational campaigns and patient awareness programs are also more prevalent here, aiding in early diagnosis and treatment.
Competitive Landscape:
Leaders in the global tumor ablation market are dedicating resources to clinical trials and research to improve the efficacy and safety of their solutions. They are also focusing on developing minimally invasive techniques to cater to patient comfort and faster recovery. Telehealth integrations are in progress to facilitate remote consultations, thereby increasing the adoption rate of their products. Regulatory approvals are a key focus, and as such, these entities are navigating complex compliance landscapes both domestically and internationally. To maintain a competitive edge, alliances with healthcare providers and medical institutions, and implementation of robust after-sales support and training programs are being formed. Furthermore, educational programs for healthcare professionals are being launched to foster proper utilization of the technology.
The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
Medtronic Public Limited Company
AngioDynamics Inc.
HealthTronics Inc.
NeuWave Medical, Inc.
INTIO Inc.
Galil Medical Ltd
Boston Scientific Corporation
SonaCare Medical LLC
EDAP TMS S.A.
Erbe Elektromedizin GmbH
IceCure Medical Ltd
MISONIX Inc.
Endocare Inc.
CooperSurgical Inc.
B V M Meditech Pvt
Recent Developments:
In August 2023, Medtronic Public Limited Company received CE (Conformitй Europйenne) Mark approval for its Inceptiv closed-loop rechargeable spinal cord stimulator (SCS). It is the first Medtronic SCS device to offer a closed-loop feature that senses each person's unique biological signals and adjusts stimulation moment to moment, as needed, to keep therapy in harmony with the motions of daily life.
In March 2023, AngioDynamics announced several new partnerships with AddLife in the UK, Ireland & Nordics markets. The new distribution arrangements will see Healthcare 21, part of the AddLife Group, distribute AngioDynamics’ oncology and surgical product portfolio in the UK and Ireland, and Mediplast in the Nordics.
In August 2023, Boston Scientific Corporation (NYSE: BSX) today announced positive 12-month results from the pivotal ADVENT clinical trial of the FARAPULSE Pulsed Field Ablation (PFA) System, a nonthermal treatment in which electric fields selectively ablate heart tissue in patients with atrial fibrillation (AF). The study is the first randomized clinical trial to directly compare the efficacy and safety of the FARAPULSE PFA System against standard-of-care ablation – either radiofrequency or cryoablation – for the treatment of patients with paroxysmal, or intermittent, AF.
Key Questions Answered in This Report
1. What was the size of the global tumor ablation market in 2023?
2. What is the expected growth rate of the global tumor ablation market during 2024-2032?
3. What has been the impact of COVID-19 on the global tumor ablation market?
4. What are the key factors driving the global tumor ablation market?
5. What is the breakup of the global tumor ablation market based on the technology?
6. What is the breakup of the global tumor ablation market based on the mode of treatment?
7. What is the breakup of the global tumor ablation market based on mode of application?
8. What is the breakup of the global tumor ablation market based on the end-user?
9. What are the key regions in the global tumor ablation market?
10. Who are the key players/companies in the global tumor ablation market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL TUMOR ABLATION MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Technology
5.5 Market Breakup by Mode of Treatment
5.6 Market Breakup by Mode of Application
5.7 Market Breakup by End-User
5.8 Market Breakup by Region
5.9 Market Forecast
6 SWOT ANALYSIS
6.1 Overview
6.2 Strengths
6.3 Weaknesses
6.4 Opportunities
6.5 Threats
7 VALUE CHAIN ANALYSIS
8 PORTER’S FIVE FORCES ANALYSIS
8.1 Overview
8.2 Bargaining Power of Buyers
8.3 Bargaining Power of Suppliers
8.4 Degree of Competition
8.5 Threat of New Entrants
8.6 Threat of Substitutes
9 MARKET BREAKUP BY TECHNOLOGY
9.1 Radiofrequency (RF) Ablation
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Microwave Ablation
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Cryoablation
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 MARKET BREAKUP BY MODE OF TREATMENT
10.1 Percutaneous Ablation
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Laparoscopic Ablation
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Surgical Ablation
10.3.1 Market Trends
10.3.2 Market Forecast
11 MARKET BREAKUP BY MODE OF APPLICATION
11.1 Liver Cancer
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Lung Cancer
11.2.1 Market Trends
11.2.2 Market Forecast
11.3 Kidney Cancer
11.3.1 Market Trends
11.3.2 Market Forecast
11.4 Bone Metastasis
11.4.1 Market Trends
11.4.2 Market Forecast
11.5 Others
11.5.1 Market Trends
11.5.2 Market Forecast
12 MARKET BREAKUP BY END-USER
12.1 Hospitals
12.1.1 Market Trends
12.1.2 Market Forecast
12.2 Cancer Specialty Clinics
12.2.1 Market Trends
12.2.2 Market Forecast
12.3 Others
12.3.1 Market Trends
12.3.2 Market Forecast
13 MARKET BREAKUP BY REGION
13.1 North America
13.1.1 Market Trends
13.1.2 Market Forecast
13.2 Europe
13.2.1 Market Trends
13.2.2 Market Forecast
13.3 Asia Pacific
13.3.1 Market Trends
13.3.2 Market Forecast
13.4 Middle East and Africa
13.4.1 Market Trends
13.4.2 Market Forecast
13.5 Latin America
13.5.1 Market Trends
13.5.2 Market Forecast
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Medtronic Public Limited Company
15.3.2 AngioDynamics Inc.
15.3.3 HealthTronics Inc.
15.3.4 NeuWave Medical, Inc.
15.3.5 INTIO Inc.
15.3.6 Galil Medical Ltd
15.3.7 Boston Scientific Corporation
15.3.8 SonaCare Medical LLC
15.3.9 EDAP TMS S.A.
15.3.10 Erbe Elektromedizin GmbH
15.3.11 IceCure Medical Ltd
15.3.12 MISONIX Inc.
15.3.13 Endocare Inc.
15.3.14 CooperSurgical Inc.
15.3.15 B V M Meditech Pvt
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL TUMOR ABLATION MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Technology
5.5 Market Breakup by Mode of Treatment
5.6 Market Breakup by Mode of Application
5.7 Market Breakup by End-User
5.8 Market Breakup by Region
5.9 Market Forecast
6 SWOT ANALYSIS
6.1 Overview
6.2 Strengths
6.3 Weaknesses
6.4 Opportunities
6.5 Threats
7 VALUE CHAIN ANALYSIS
8 PORTER’S FIVE FORCES ANALYSIS
8.1 Overview
8.2 Bargaining Power of Buyers
8.3 Bargaining Power of Suppliers
8.4 Degree of Competition
8.5 Threat of New Entrants
8.6 Threat of Substitutes
9 MARKET BREAKUP BY TECHNOLOGY
9.1 Radiofrequency (RF) Ablation
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Microwave Ablation
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Cryoablation
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 MARKET BREAKUP BY MODE OF TREATMENT
10.1 Percutaneous Ablation
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Laparoscopic Ablation
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Surgical Ablation
10.3.1 Market Trends
10.3.2 Market Forecast
11 MARKET BREAKUP BY MODE OF APPLICATION
11.1 Liver Cancer
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Lung Cancer
11.2.1 Market Trends
11.2.2 Market Forecast
11.3 Kidney Cancer
11.3.1 Market Trends
11.3.2 Market Forecast
11.4 Bone Metastasis
11.4.1 Market Trends
11.4.2 Market Forecast
11.5 Others
11.5.1 Market Trends
11.5.2 Market Forecast
12 MARKET BREAKUP BY END-USER
12.1 Hospitals
12.1.1 Market Trends
12.1.2 Market Forecast
12.2 Cancer Specialty Clinics
12.2.1 Market Trends
12.2.2 Market Forecast
12.3 Others
12.3.1 Market Trends
12.3.2 Market Forecast
13 MARKET BREAKUP BY REGION
13.1 North America
13.1.1 Market Trends
13.1.2 Market Forecast
13.2 Europe
13.2.1 Market Trends
13.2.2 Market Forecast
13.3 Asia Pacific
13.3.1 Market Trends
13.3.2 Market Forecast
13.4 Middle East and Africa
13.4.1 Market Trends
13.4.2 Market Forecast
13.5 Latin America
13.5.1 Market Trends
13.5.2 Market Forecast
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Medtronic Public Limited Company
15.3.2 AngioDynamics Inc.
15.3.3 HealthTronics Inc.
15.3.4 NeuWave Medical, Inc.
15.3.5 INTIO Inc.
15.3.6 Galil Medical Ltd
15.3.7 Boston Scientific Corporation
15.3.8 SonaCare Medical LLC
15.3.9 EDAP TMS S.A.
15.3.10 Erbe Elektromedizin GmbH
15.3.11 IceCure Medical Ltd
15.3.12 MISONIX Inc.
15.3.13 Endocare Inc.
15.3.14 CooperSurgical Inc.
15.3.15 B V M Meditech Pvt
LIST OF TABLES
Table 1: Global: Tumor Ablation Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Tumor Ablation Market Forecast: Breakup by Technology (in Million US$), 2024-2032
Table 3: Global: Tumor Ablation Market Forecast: Breakup by Mode of Treatment (in Million US$), 2024-2032
Table 4: Global: Tumor Ablation Market Forecast: Breakup by Mode of Application (in Million US$), 2024-2032
Table 5: Global: Tumor Ablation Market Forecast: Breakup by End-User (in Million US$), 2024-2032
Table 6: Global: Tumor Ablation Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Tumor Ablation Market Structure
Table 8: Global: Tumor Ablation Market: Key Players
Table 1: Global: Tumor Ablation Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Tumor Ablation Market Forecast: Breakup by Technology (in Million US$), 2024-2032
Table 3: Global: Tumor Ablation Market Forecast: Breakup by Mode of Treatment (in Million US$), 2024-2032
Table 4: Global: Tumor Ablation Market Forecast: Breakup by Mode of Application (in Million US$), 2024-2032
Table 5: Global: Tumor Ablation Market Forecast: Breakup by End-User (in Million US$), 2024-2032
Table 6: Global: Tumor Ablation Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Tumor Ablation Market Structure
Table 8: Global: Tumor Ablation Market: Key Players
LIST OF FIGURES
Figure 1: Global: Tumor Ablation Market: Major Drivers and Challenges
Figure 2: Global: Tumor Ablation Market: Sales Value (in Million US$), 2018-2023
Figure 3: Global: Tumor Ablation Market: Breakup by Technology (in %), 2023
Figure 4: Global: Tumor Ablation Market: Breakup by Mode of Treatment (in %), 2023
Figure 5: Global: Tumor Ablation Market: Breakup by Mode of Application (in %), 2023
Figure 6: Global: Tumor Ablation Market: Breakup by End-User (in %), 2023
Figure 7: Global: Tumor Ablation Market: Breakup by Region (in %), 2023
Figure 8: Global: Tumor Ablation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 9: Global: Tumor Ablation Industry: SWOT Analysis
Figure 10: Global: Tumor Ablation Industry: Value Chain Analysis
Figure 11: Global: Tumor Ablation Industry: Porter’s Five Forces Analysis
Figure 12: Global: Tumor Ablation (Radiofrequency Ablation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Tumor Ablation (Radiofrequency Ablation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Tumor Ablation (Microwave Ablation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Tumor Ablation (Microwave Ablation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Tumor Ablation (Cryoablation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Tumor Ablation (Cryoablation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Tumor Ablation (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Tumor Ablation (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Tumor Ablation (Percutaneous Ablation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Tumor Ablation (Percutaneous Ablation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Tumor Ablation (Laparoscopic Ablation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Tumor Ablation (Laparoscopic Ablation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Tumor Ablation (Surgical Ablation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Tumor Ablation (Surgical Ablation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Tumor Ablation (Liver Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Tumor Ablation (Liver Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Tumor Ablation (Lung Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Tumor Ablation (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Tumor Ablation (Kidney Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Tumor Ablation (Kidney Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: Tumor Ablation (Bone Metastasis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Tumor Ablation (Bone Metastasis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Global: Tumor Ablation (Other Mode of Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Global: Tumor Ablation (Other Mode of Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Global: Tumor Ablation (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Global: Tumor Ablation (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Global: Tumor Ablation (Cancer Specialty Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Global: Tumor Ablation (Cancer Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Global: Tumor Ablation (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Global: Tumor Ablation (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: North America: Tumor Ablation Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: North America: Tumor Ablation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Europe: Tumor Ablation Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Europe: Tumor Ablation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Asia Pacific: Tumor Ablation Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Asia Pacific: Tumor Ablation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Middle East and Africa: Tumor Ablation Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Middle East and Africa: Tumor Ablation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Latin America: Tumor Ablation Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Latin America: Tumor Ablation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 1: Global: Tumor Ablation Market: Major Drivers and Challenges
Figure 2: Global: Tumor Ablation Market: Sales Value (in Million US$), 2018-2023
Figure 3: Global: Tumor Ablation Market: Breakup by Technology (in %), 2023
Figure 4: Global: Tumor Ablation Market: Breakup by Mode of Treatment (in %), 2023
Figure 5: Global: Tumor Ablation Market: Breakup by Mode of Application (in %), 2023
Figure 6: Global: Tumor Ablation Market: Breakup by End-User (in %), 2023
Figure 7: Global: Tumor Ablation Market: Breakup by Region (in %), 2023
Figure 8: Global: Tumor Ablation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 9: Global: Tumor Ablation Industry: SWOT Analysis
Figure 10: Global: Tumor Ablation Industry: Value Chain Analysis
Figure 11: Global: Tumor Ablation Industry: Porter’s Five Forces Analysis
Figure 12: Global: Tumor Ablation (Radiofrequency Ablation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Tumor Ablation (Radiofrequency Ablation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Tumor Ablation (Microwave Ablation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Tumor Ablation (Microwave Ablation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Tumor Ablation (Cryoablation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Tumor Ablation (Cryoablation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Tumor Ablation (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Tumor Ablation (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Tumor Ablation (Percutaneous Ablation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Tumor Ablation (Percutaneous Ablation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Tumor Ablation (Laparoscopic Ablation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Tumor Ablation (Laparoscopic Ablation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Tumor Ablation (Surgical Ablation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Tumor Ablation (Surgical Ablation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Tumor Ablation (Liver Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Tumor Ablation (Liver Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Tumor Ablation (Lung Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Tumor Ablation (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Tumor Ablation (Kidney Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Tumor Ablation (Kidney Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: Tumor Ablation (Bone Metastasis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Tumor Ablation (Bone Metastasis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Global: Tumor Ablation (Other Mode of Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Global: Tumor Ablation (Other Mode of Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Global: Tumor Ablation (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Global: Tumor Ablation (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Global: Tumor Ablation (Cancer Specialty Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Global: Tumor Ablation (Cancer Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Global: Tumor Ablation (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Global: Tumor Ablation (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: North America: Tumor Ablation Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: North America: Tumor Ablation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Europe: Tumor Ablation Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Europe: Tumor Ablation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Asia Pacific: Tumor Ablation Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Asia Pacific: Tumor Ablation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Middle East and Africa: Tumor Ablation Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Middle East and Africa: Tumor Ablation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Latin America: Tumor Ablation Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Latin America: Tumor Ablation Market Forecast: Sales Value (in Million US$), 2024-2032
